Clinical Trial

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-04-08; most recent amendment 2026-03-03.
Status change: Completed → Recruiting 2024-12-18
Status change: Recruiting → Completed 2023-12-20
Status change: Not Yet Recruiting → Recruiting 2021-09-21
Trial Details
NCT Number NCT04843371
Lead Sponsor Tulane University
Conditions Valvular Heart Disease, Pericardial Disease, Cardiomyopathies
Enrollment 500 participants
Start Date 2021-08-20
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-05